Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient
Authors not listed
Centre Hospitalier Universitaire de Besancon · 2014
Abstract
The aim of this study is to investigate the role of immunosenescence in the HBV vaccination response in patients with renal insufficiency.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Anonymous. (2014). Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient. <em>Centre Hospitalier Universitaire de Besancon</em>. https://clinicaltrials.gov/study/NCT02375711
Vancouver
Anonymous. Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient. Centre Hospitalier Universitaire de Besancon. 2014.
BibTeX
@misc{anon2014Evalua,
title = {Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient},
author = {Anonymous},
journal = {Centre Hospitalier Universitaire de Besancon},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Centre Hospitalier Universitaire de Besancon 2013
Open access · US-GOV
Accelerated Immunosenescence and Chronic Kidney Disease
Neurologic Clinics 2016
Citation only
Epidemiology of Parkinson Disease
Huashan Hospital 2024
Open access · US-GOV
Ketosteril Sarcopenia Chronic Kidney Disease
University of Alberta 2016
Open access · US-GOV
Decreasing the Burden of Sarcopenia in Cancer Through Targeted Nutrition Intervention: A Feasibility Study
Biochemical and biophysical research communications 2026
Citation only
Renal tubular epithelial-derived Angptl4 promotes renal fibrosis by inducing tubular cell senescence.
Frontiers in Immunology 2026
Open access · CC-BY